AKK finds no violations of Coronavirus test prices, no complaints from citizens

Director of the Kosovo Competition Authority (AKK) have declared that they have not found any irregularities in private labs licensed by the Health Ministry for testing of the SARS CoV 2 virus. At the media conference regarding monitoring prices for testing for the SARS-Cov-2 virus, Muhamet Krasniqi, a member of the Commission, stressed that from 118 labs [...]
Director of the Kosovo Competition Authority (AKK) have declared that they have not found any irregularities in private labs licensed by the Health Ministry for testing of the SARS CoV 2 virus.
At the media conference related to monitoring prices for testing for the SARS-Cov-2 virus, Muhamet Krasniqi, a member of the Commission, stressed that of 118 licensed labs, given information that has failed to identify any behavior that raises doubts about the obsession of these services or the co-ordination of activities among operators that may conflict with the Competition Law.
After the Board's decision to license private health institutions for testing services for Sars-Cov-2, the Kosovo Competition Authority has pledged that it will be uncompetitive in the fight to avoid correct behavioral deviations in the market. Of the data provided so far are a total of 118 labs licensed for conducting tests for the Sras-Cov-2 virus in Kosovo. Based on the information we have collected, the Competition Authority has failed to identify any behavior that raises doubts about the price fixing of these services or the co-ordination of activity among operators that may conflict with competition laws. So, we're dealing with a market that's functioning well at least so far. There is also a liberalised market”, Krasniqi said.
Also at this conference, Rizah Arifi, leader of the Private Lab Monitoring Group, said the AKK has not accepted any complaints from citizens about any irregularities for private labs that conduct tests for coronarys.
“Linked to the licensing of these labs from the Health Ministry, we have no complaint from Kosovo citizens about any irregularities in this matter”, Arifi stressed.
Meanwhile, for price differences in medicines, Muhamet Krasniqi has said that determining prices in fiscal books differently with prices communicated for citizens is the responsibility of the Market Inspectorate.












